Avner Reshef

Avner Reshef

UNVERIFIED PROFILE

Are you Avner Reshef?   Register this Author

Register author
Avner Reshef

Avner Reshef

Publications by authors named "Avner Reshef"

Are you Avner Reshef?   Register this Author

32Publications

716Reads

-Profile Views

A Structured Gradual Exposure Protocol to Baked and Heated Milk in the Treatment of Milk Allergy.

J Pediatr 2018 12 27;203:204-209.e2. Epub 2018 Sep 27.

Clinical Allergy and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Clalit Health Services, Tel Aviv, Israel; Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel; Allergy and Clinical Immunology Unit, Sheba Medical Center, Tel Hashomer, Israel.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00223476183109
Publisher Site
http://dx.doi.org/10.1016/j.jpeds.2018.07.091DOI Listing
December 2018

Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.

J Allergy Clin Immunol Pract 2017 Nov - Dec;5(6):1671-1678.e2. Epub 2017 Jun 7.

Institute for Asthma and Allergy, Chevy Chase, Md.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2017.04.010DOI Listing
June 2018

Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.

J Allergy Clin Immunol Pract 2017 Jul - Aug;5(4):1091-1097. Epub 2017 Feb 13.

Department of Medicine, Division of Rheumatology, Allergy, & Immunology, University of California San Diego, San Diego, Calif.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2016.11.005DOI Listing
January 2018

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.

N Engl J Med 2017 03;376(12):1131-1140

From Barts Health NHS Trust (H.L.) and St. John's Institute of Dermatology, Guy's Hospital (C.G.), London, and the Clinical Investigation and Research Unit, Royal Sussex County Hospital, Brighton (M.T.) - all in the United Kingdom; Ospedale Luigi Sacco-U.O. Medicina Generale, Milan (M.C.), and the Department of Internal Medicine, University of Catania, Catania (S.N.) - both in Italy; Department of Medicine and Pediatrics, Penn State Hershey Allergy, Asthma, and Immunology, Hershey (T. Craig), and CSL Behring, King of Prussia (D.B.-K., J.E., D.P.) - both in Pennsylvania; the Department of Dermatology, Johannes Gutenberg University Mainz, Mainz (K.B.), and CSL Behring, Marburg (H. Feuersenger, J.-P.L., T.M., I.P.) - both in Germany; Baker Allergy, Asthma and Dermatology Research Center, Portland, OR (J. Baker); Institute for Asthma and Allergy, Chevy Chase, MD (H.H.L.); Allergy and Immunology Unit, Chaim Sheba Medical Center, Tel Hashomer (A.R.), and Allergy and Immunology Unit, Tel Aviv Sourasky Medical Center, Tel Aviv (S.K.) - both in Israel; Clinical Research Center of Alabama, Birmingham (J. Bonner, J.A.); Department of Internal Medicine, Allergy Section Cincinnati, University of Cincinnati College of Medicine, Cincinnati (J.A.B.), and Toledo Institute of Clinical Research, Toledo (S.M.R.) - both in Ohio; Allergy Asthma Research Associates Research Center, Dallas (W.R.L.); Hungarian Angioedema Center, Third Department of Internal Medicine, Semmelweis University, Budapest (H. Farkas); the Department of Medicine, Immunology, and Allergy, Campbelltown Hospital, Campbelltown, NSW, Australia (C.H.K.); the Department of Clinical Immunology and Allergy, St. Michael's Hospital, Toronto (G.L.S.), Centre de Recherche Appliqué en Allergie de Québec, Quebec, QC (J.H.), McMaster University, Hamilton, ON (P.K.K.), Ottawa Allergy Research and University of Ottawa Medical School, Ottawa (W.Y.), and University of Alberta Hospital, Edmonton (B.R.) - all in Canada; Allergy and Asthma Clinical Research, Walnut Creek (J.J.), University of California, San Diego School of Medicine, La Jolla (M.R., B.L.Z.), and 705 W. La Veta Ave., Suite 101, Orange (D.S.L.) - all in California; Medical Research of Arizona, Scottsdale (M.E.M.); Hospital General Universitario Gregorio Marañón and Biomedical Research Network on Rare Diseases-U761, Institute for Health Research, Gregorio Marañón (M.L.B.), and the Allergy Department, Hospital La Paz Institute for Health Research, Biomedical Research Network on Rare Diseases (T. Caballero), Madrid, the Allergy Department, IIS Hospital Universitario La Fe, Valencia (M.D.H.), and Hospital Universitario Vall d'Hebron, Barcelona (M.G.) - all in Spain; Asthma and Allergy Association, Colorado Springs, CO (R.N.); Department of Internal Medicine, Virginia Commonwealth University, Richmond (L.B.S.); Spitalul Clinic Municipal, Cluj-Napoca, Romania (I.C.); Vital Prospects Clinical Research Institute, Tulsa, OK (I.H.); Institute of Clinical Immunology and Allergology, University Hospital, Hradec Kralove, Czech Republic (P.K.); Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston (A.B.); and Marycliff Allergy Specialists, Spokane, WA (R.G.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1613627DOI Listing
March 2017

The Story of Angioedema: from Quincke to Bradykinin.

Clin Rev Allergy Immunol 2016 Oct;51(2):121-39

Angioedema Center, Allergy & Clinical Immunology, Sheba Medical Center, Tel Hashomer, Ramat Gan, 52621, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-016-8553-8DOI Listing
October 2016

Urticaria: Enigmatic but Manageable Illness.

Authors:
Avner Reshef

Isr Med Assoc J 2016 Aug;18(8):493-494

Angioedema Center, Allergy.

View Article

Download full-text PDF

Source
August 2016

Hereditary angioedema: A call for collective terminology.

Authors:
Avner Reshef

Allergy Asthma Proc 2016 Jan-Feb;37(1):e14

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2500/aap.2015.36.3900DOI Listing
June 2016

Impact of an extended challenge on the effectiveness of β-lactam hypersensitivity investigation.

Ann Allergy Asthma Immunol 2016 Apr 26;116(4):329-33. Epub 2016 Feb 26.

Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allergy and Immunology Unit, Sheba Medical Center, Tel Hashomer, Israel; Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anai.2016.01.018DOI Listing
April 2016

Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.

J Allergy Clin Immunol Pract 2015 May-Jun;3(3):417-23. Epub 2015 Feb 11.

UCSD School of Medicine, La Jolla, Calif.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2014.12.013DOI Listing
February 2016

Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys.

Allergy Asthma Proc 2013 May-Jun;34(3):261-6

Department of Allergy, Immunology, and Angioedema Center, Sheba Medical Center, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2500/aap.2013.34.3663DOI Listing
October 2013

The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach?

Allergy 2013 Sep;68(9):1207-9

Department of Clinical and Environmental Allergology, Jagiellonian University, Krakow, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/all.12165DOI Listing
September 2013

Reply: To PMID 23121116.

Allergy 2013 Sep;68(9):1208-9

View Article

Download full-text PDF

Source
September 2013

C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.

Pediatr Allergy Immunol 2013 Feb 22;24(1):54-60. Epub 2012 Nov 22.

Division of Immunology, Boston Children's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pai.12024DOI Listing
February 2013

[Chronic rhinitis--clinical guidelines 2010].

Harefuah 2011 Mar;150(3):275-8, 302

Sheba Medical Center, Tel-Hashomer.

View Article

Download full-text PDF

Source
March 2011

Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.

Ann Allergy Asthma Immunol 2010 Aug;105(2):149-54

Division of Immunology/Allergy, Department of Internal Medicine, University of Cincinnati Medical Center and Bernstein Clinical Research Center, Cincinnati, Ohio 45267-0563, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anai.2010.06.005DOI Listing
August 2010

Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department.

Ann Allergy Asthma Immunol 2009 Dec;103(6):502-7

Montgomery Family Practice Residency Program, Montgomery Hospital Medical Center, Norristown, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1081-1206(10)60267-0DOI Listing
December 2009

[Hereditary angioedema: new mechanisms and therapeutic options].

Harefuah 2009 Aug;148(8):529-34, 571

Allergy and Clinical Immunology and the Angioedema Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

View Article

Download full-text PDF

Source
August 2009

Hereditary angioedema: new hopes for an orphan disease.

Isr Med Assoc J 2008 Dec;10(12):850-5

Allergy and Immunology Unit and Angioedema Center, Sheba Medical Center, Tel Hashomer, Israel.

View Article

Download full-text PDF

Source
December 2008